MDT

89.67

-0.09%↓

VEEV

276.66

-1.93%↓

A

116.42

+2.59%↑

WBA

11.51

-0.09%↓

HQY

100.13

+2.61%↑

MDT

89.67

-0.09%↓

VEEV

276.66

-1.93%↓

A

116.42

+2.59%↑

WBA

11.51

-0.09%↓

HQY

100.13

+2.61%↑

MDT

89.67

-0.09%↓

VEEV

276.66

-1.93%↓

A

116.42

+2.59%↑

WBA

11.51

-0.09%↓

HQY

100.13

+2.61%↑

MDT

89.67

-0.09%↓

VEEV

276.66

-1.93%↓

A

116.42

+2.59%↑

WBA

11.51

-0.09%↓

HQY

100.13

+2.61%↑

MDT

89.67

-0.09%↓

VEEV

276.66

-1.93%↓

A

116.42

+2.59%↑

WBA

11.51

-0.09%↓

HQY

100.13

+2.61%↑

Search

Pacific Biosciences of California Inc

Fermé

SecteurSoins de santé

1.38 -6.76

Résumé

Variation du prix de l'action

24h

Actuel

Min

1.36

Max

1.49

Chiffres clés

By Trading Economics

Revenu

-428M

-426M

Ventes

-2.1M

37M

Marge bénéficiaire

-1,146.812

Employés

575

EBITDA

-420M

-403M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+46.31% upside

Dividendes

By Dow Jones

Prochains Résultats

6 août 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

99M

438M

Ouverture précédente

8.14

Clôture précédente

1.38

Sentiment de l'Actualité

By Acuity

64%

36%

335 / 376 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bullish Evidence

Pacific Biosciences of California Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

17 juil. 2025, 23:34 UTC

Acquisitions, Fusions, Rachats

FTC Reopens Consent Orders for Proposed Acquisitions from Exxon Mobil, Chevron

17 juil. 2025, 21:14 UTC

Acquisitions, Fusions, Rachats

Basel Medical Group Puts $1 Billion Bitcoin Purchase on Hold

17 juil. 2025, 21:04 UTC

Principaux Mouvements du Marché
Acquisitions, Fusions, Rachats

Norfolk Southern Shares Rise on WSJ Report of Union Pacific Acquisition Interest

17 juil. 2025, 23:43 UTC

Market Talk

Gold Edges Higher on Possible Position Adjustments -- Market Talk

17 juil. 2025, 23:42 UTC

Market Talk

Nikkei May Rise on Signs of U.S. Econ Strength -- Market Talk

17 juil. 2025, 22:47 UTC

Acquisitions, Fusions, Rachats

FTC: Maintaining Restrictions for Former Pioneer CEO Scott Sheffield Would Damage FTC's Credibility

17 juil. 2025, 22:46 UTC

Acquisitions, Fusions, Rachats

Potential Rail Merger Could Prompt Berkshire Hathaway to Bid for CSX -- Barrons.com

17 juil. 2025, 22:46 UTC

Acquisitions, Fusions, Rachats

FTC Also Says Exxon Order Disregarded Guidelines and Precedent

17 juil. 2025, 22:43 UTC

Acquisitions, Fusions, Rachats

FTC: Maintaining Restrictions on John Hess's Employment Would 'Damage the FTC's Credibility'

17 juil. 2025, 22:43 UTC

Acquisitions, Fusions, Rachats

FTC: Chevron Order Disregarded FTC Merger Guidelines and Decades of Precedent

17 juil. 2025, 22:40 UTC

Acquisitions, Fusions, Rachats

FTC Reopens and Sets Aside Chevron-Hess and Exxon-Pioneer Final Consent Orders

17 juil. 2025, 22:40 UTC

Acquisitions, Fusions, Rachats

FTC Reopens and Sets Aside Chevron-Hess and Exxon-Pioneer Final Consent Orders

17 juil. 2025, 22:30 UTC

Market Talk
Résultats

Netflix Sticks to Its Playbook as Competitive Landscape Changes -- Market Talk

17 juil. 2025, 22:20 UTC

Market Talk
Résultats

Global Equities Roundup: Market Talk

17 juil. 2025, 22:20 UTC

Market Talk
Résultats

Netflix Focusing Resources on TV Viewers It Hasn't Yet Captured -- Market Talk

17 juil. 2025, 22:04 UTC

Market Talk
Résultats

Netflix Redesign Done to Match Current Capabilities -- Market Talk

17 juil. 2025, 22:03 UTC

Acquisitions, Fusions, Rachats

China Threatens to Block Panama Ports Deal Unless Its Shipping Giant Is Part of It -- 2nd Update

17 juil. 2025, 21:58 UTC

Market Talk
Résultats

Netflix Internal Data Doesn't Indicate Weaker Consumer Sentiment -- Market Talk

17 juil. 2025, 21:57 UTC

Résultats

Netflix Earnings Soar Past Expectations. How a Weak Dollar Helped Boost Results. -- Barrons.com

17 juil. 2025, 21:47 UTC

Résultats

Netflix Raises Revenue, Margin Forecasts After Strong Second Quarter -- Update

17 juil. 2025, 21:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 juil. 2025, 21:45 UTC

Market Talk

Crypto Bills Welcomed by Venture Capital, Trade Group Says -- Market Talk

17 juil. 2025, 21:38 UTC

Acquisitions, Fusions, Rachats

Railroad Operator Union Pacific Exploring Deal for Norfolk Southern -- 2nd Update

17 juil. 2025, 21:22 UTC

Acquisitions, Fusions, Rachats

Update: Union Pacific Considering a Norfolk Southern Buyout: Report. -- Barrons.com

17 juil. 2025, 21:05 UTC

Résultats

Netflix Earnings Soar Past Expectations. How a Weak Dollar Helped Boost Results. -- Barrons.com

17 juil. 2025, 21:04 UTC

Acquisitions, Fusions, Rachats

Railroad Operator Union Pacific Exploring Deal for Norfolk Southern -- Update

17 juil. 2025, 21:02 UTC

Acquisitions, Fusions, Rachats

Union Pacific Considering a Norfolk Southern Buyout: Report. -- Barrons.com

17 juil. 2025, 20:59 UTC

Acquisitions, Fusions, Rachats

Basel Medical Group Puts $1B Bitcoin Purchase on Hold

17 juil. 2025, 20:50 UTC

Market Talk
Résultats

Tech, Media & Telecom Roundup: Market Talk

17 juil. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

Comparaison

Variation de prix

Pacific Biosciences of California Inc prévision

Objectif de Prix

By TipRanks

46.31% hausse

Prévisions sur 12 Mois

Moyen 2.18 USD  46.31%

Haut 3 USD

Bas 1.25 USD

Basé sur 7 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

7 ratings

4

Achat

3

Maintien

0

Vente

Score Technique

By Trading Central

1.13 / N/ASupport & Résistance

Court Terme

Bullish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

335 / 376Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Pacific Biosciences of California Inc

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.